A variety of topical and injectable therapies are showing promise for addressing the problem of hair loss in both men and women, says Matt Leavitt, D.O.
Cheryl Guttman Krader, BS, Pharm
Use of systemic therapies for treatment of melanoma is growing, and so is the list of cutaneous side effects associated with their use.
The interleukin-23 antagonist guselkumab demonstrated greater efficacy compared with adalimumab and secukinumab at week 48 in controlled clinical trials investigating treatment of moderate-to-severe plaque psoriasis.
Recent evidence of increased mast cell activity suggests mast cell stabilization as a target for rosacea treatment.
Speaking about device-based acne treatments at Maui Derm for Dermatologists 2020 meeting, Fernanda Sakamoto, Ph.D., M.D., discussed PDT and other approaches for targeting the sebaceous gland.
Designating April as Rosacea Awareness Month, the National Rosacea Society aims to increase public understanding of the condition and lead individuals who may be affected to seek medical help before their condition becomes worse.
Glynis R. Ablon, M.D., spoke at the 18th annual South Beach Symposium in Miami about why microneedling with radiofrequency is an effective way to combat signs of aging skin. According to Dr. Ablon, benefits include minimal downtime and risk versus other options.
Read more on the variety of new treatment options for acne, with even more awaiting approval.
Read insights from James Q. Del Rosso, D.O., as he discusses antibiotic resistance, isotretinoin relapse, and laboratory monitoring for patients on isotretinoin and spironolactone.
Published results from two 12-week, vehicle-controlled phase 3 studies show that a novel topical foam formulation of minocycline 1.5% may be effective in reducing inflammatory lesions.